SC 13G/A | 2024-02-14 | Point72 Asset Management, L.P. | Esperion Therapeutics, Inc. | 4,800 | 0.2% | EDGAR |
SC 13G/A | 2024-02-14 | CVI Investments, Inc. | Esperion Therapeutics, Inc. | 0 | 0.0% | EDGAR |
SC 13G/A | 2024-02-14 | Deep Track Capital, LP | Esperion Therapeutics, Inc. | 0 | 0.0% | EDGAR |
SC 13G/A | 2024-02-14 | Two Seas Capital LP | Esperion Therapeutics, Inc. | 7,686,120 | 6.8% | EDGAR |
SC 13G/A | 2024-02-13 | VANGUARD GROUP INC | Esperion Therapeutics, Inc. | 5,137,750 | 4.5% | EDGAR |
SC 13G/A | 2024-02-09 | WASATCH ADVISORS LP | Esperion Therapeutics, Inc. | - | - | EDGAR |
SC 13G/A | 2024-01-24 | BB BIOTECH AG | Esperion Therapeutics, Inc. | 4,194,064 | 3.7% | EDGAR |
SC 13G/A | 2024-01-24 | BB BIOTECH AG | Esperion Therapeutics, Inc. | 9,194,064 | 5.1% | EDGAR |
SC 13G/A | 2024-01-17 | MILLENNIUM MANAGEMENT LLC | Esperion Therapeutics, Inc. | 3,643,951 | 3.2% | EDGAR |
SC 13G/A | 2024-01-03 | Meditor Group Ltd | Esperion Therapeutics, Inc. | 3,791,300 | 3.3% | EDGAR |
SC 13G | 2023-10-05 | Two Seas Capital LP | Esperion Therapeutics, Inc. | 7,922,170 | 7.4% | EDGAR |
SC 13G | 2023-08-29 | MILLENNIUM MANAGEMENT LLC | Esperion Therapeutics, Inc. | 5,366,452 | 5.0% | EDGAR |
SC 13G | 2023-08-28 | MILLENNIUM MANAGEMENT LLC | Esperion Therapeutics, Inc. | 5,223,439 | 4.9% | EDGAR |
SC 13G/A | 2023-06-08 | BlackRock Inc. | Esperion Therapeutics, Inc. | 4,645,359 | 4.9% | EDGAR |
SC 13G | 2023-04-05 | Point72 Asset Management, L.P. | Esperion Therapeutics, Inc. | 4,314,286 | 4.8% | EDGAR |
SC 13G/A | 2023-02-14 | Point72 Asset Management, L.P. | Esperion Therapeutics, Inc. | 2,277,000 | 4.0% | EDGAR |
SC 13G/A | 2023-02-14 | CVI Investments, Inc. | Esperion Therapeutics, Inc. | 5,500,000 | 6.9% | EDGAR |
SC 13G/A | 2023-02-14 | BB BIOTECH AG | Esperion Therapeutics, Inc. | 4,194,064 | 5.7% | EDGAR |
SC 13G/A | 2023-02-10 | WASATCH ADVISORS INC | Esperion Therapeutics, Inc. | - | - | EDGAR |
SC 13G/A | 2023-02-09 | VANGUARD GROUP INC | Esperion Therapeutics, Inc. | 4,260,464 | 5.8% | EDGAR |